<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000803674">
  <TermName>Valchlor</TermName>
  <TermPronunciation>(VAL-klor)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used on the skin    to treat stage I mycosis fungoides (a type of cutaneous T-cell lymphoma) in patients who have already been treated with other therapy. It is also being studied in the treatment of other types of cancer.  Valchlor damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent. Also called mechlorethamine hydrochloride and mustine.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000805349" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Valchlor&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000805350" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Valchlor&quot;" language="es" id="_4"/>
  <SpanishTermName>Valchlor</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa en la piel para el tratamiento de la micosis fungoide en estadio I (tipo de linfoma cutáneo de células T) en pacientes que ya recibieron otra terapia.  También está en estudio para el tratamiento de otros tipos de cáncer.  Valchlor daña el ADN de las células y es posible que destruya células cancerosas. Es un tipo de alquilante. También se llama clorhidrato de clormetina y mustina.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2020-12-21</DateFirstPublished>
  <DateLastModified>2020-12-21</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000708114" url="/about-cancer/treatment/drugs/mechlorethaminehydrochloride">Mechlorethamine Hydrochloride</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
